The global Positron Emission Tomography (PET) market is set to witness a growth rate of 5% in the next 5 years. Growing prevalence of chronic diseases; technological advancements in ...

Learn how PET study shows safe, targeted brain delivery of intranasal insulin, a critical step for future Alzheimer’s ...

Positron Emission Tomography (PET) Scanners Global Market Overview 2021-2023 & 2024-2030 - ResearchAndMarkets.com February 17, 2025 10:25 AM Eastern Standard Time ...

The AHL2011 study (ClinicalTrials.gov identifier: NCT01358747) demonstrated that a positron emission tomography (PET)-driven de-escalation strategy after two cycles of bleomycin, etoposide, ...

The article by LaCasce et al entitled “Positron Emission Tomography–Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)” (J Clin Oncol 10.1200/JCO.22.00947) was ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

More than 500 nuclear medicine facilities are available in the government and private sectors, Union Minister of State for ...

Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network June 24, 2024 02:15 PM Eastern Daylight Time ...